Alexey A. Lugovskoy
Amministratore Delegato presso Diagonal Therapeutics, Inc.
Profilo
Alexey A.
Lugovskoy is the founder and the Chief Executive Officer of Diagonal Therapeutics, Inc., which was founded in 2022.
He is also currently an Advisory Board Member at RusBioVentures LLC since 2013.
In the past, Dr. Lugovskoy held the position of Associate Director-Drug Discovery at Biogen, Inc. from 2001 to 2010.
He then served as Vice President-Therapeutics at Merrimack Pharmaceuticals, Inc. from 2010 to 2016.
Additionally, he held the role of Chief Development Officer at Morphic Holding, Inc. and Chief Operating Officer at Dragonfly Therapeutics, Inc.Dr. Lugovskoy's education includes a doctorate degree from Harvard University.
He also holds a graduate degree from the Massachusetts Institute of Technology, where he graduated in 1998.
He completed his undergraduate and graduate studies at Moscow Institute of Physics & Technology, and received his undergraduate degree from Ryazan State Radio Technical University in 1992.
Posizioni attive di Alexey A. Lugovskoy
| Società | Posizione | Inizio |
|---|---|---|
RusBioVentures LLC
 RusBioVentures LLC Investment ManagersFinance RusBioVentures LLC (RBV Capital) is a venture capital firm founded in 2014 by Alexey Konov. The firm is headquartered in Moscow, Russia. | Consulente / Consigliere | 01/01/2013 |
Diagonal Therapeutics, Inc.
 Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Diagonal Therapeutics, Inc. is a biotechnology company located in the US that develops drugs for oncology, immunology, and rare diseases. | Amministratore Delegato | 01/01/2022 |
Precedenti posizioni note di Alexey A. Lugovskoy
| Società | Posizione | Fine |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2016 |
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2010 |
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Direttore operativo | - |
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | - |
Formazione di Alexey A. Lugovskoy
| Harvard University | Doctorate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| Moscow Institute of Physics & Technology | Graduate Degree |
| Ryazan State Radio Technical University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
RusBioVentures LLC
RusBioVentures LLC Investment ManagersFinance RusBioVentures LLC (RBV Capital) is a venture capital firm founded in 2014 by Alexey Konov. The firm is headquartered in Moscow, Russia. | Finance |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Health Technology |
Diagonal Therapeutics, Inc.
Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Diagonal Therapeutics, Inc. is a biotechnology company located in the US that develops drugs for oncology, immunology, and rare diseases. | Health Technology |
- Borsa valori
- Insiders
- Alexey A. Lugovskoy
